Synthesis, structure, protolytic properties, alkylating and cytotoxic activity of novel platinum(II) and palladium(II) complexes with pyrazole-derived ligands

European Journal of Inorganic Chemistry

Volumn , Issue 23, 2007, Pages 3728-3735

  Budzisz, Elzbieta ^a   Malecka, Magdalena ^b   Keppler, Bernhard K ^c   Arion, Vladimir B ^c   Andrijewski, Grzegorz ^b   Krajewska, Urszula ^a   Rozalski, Marek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Alkylating and cytotoxic activity; Antitumor agents; Metal complexes; Palladium; Platinum; Pyrazole ligands

Indexed keywords

CELL CULTURE; CHELATION; CYTOTOXICITY; INDIUM COMPOUNDS; LIGANDS; MASS SPECTROMETRY; PALLADIUM COMPOUNDS; PLATINUM COMPOUNDS; SYNTHESIS (CHEMICAL); X RAY DIFFRACTION;

2-HYDROXYBENZOYL; ALKYLATING ACTIVITY; ANTICANCER COMPOUNDS; ANTITUMOUR AGENTS; CYTOTOXIC ACTIVITIES; PROTOLYTIC PROPERTIES; PROTONATION CONSTANTS; PYRAZOLE LIGANDS; PYRAZOLES; SYNTHESISED;

METAL COMPLEXES;

EID: 34548096475     PISSN: 14341948     EISSN: 10990682     Source Type: Journal    
DOI: 10.1002/ejic.200700139     Document Type: Article

References (67)

1. J. Reedijk, Curr. Opin. Chem. Biol. 1999, 3, 236-240.
2. M. A. Jakupec, M. Galanski, B. K. Keppler, Rev. Physiol. Bi ochem. Pharmacol. 2003, 146, 1-53.
3. E. R. Jamieson, S. J. Lippard, Chem. Rev. 1999, 99, 2467-2498, and references cited therein.
4. P. Garnuszek, J. Licinska, J. S. Skierski, M. Koronkiewicz, M. Mirowski, R. Wiercioch, A. P. Mazurek, Nucl. Med. Biol. 2002, 29, 169-175.
5. J. Zhang, X. Zhao, Eur. J. Med. Chem. 2006, 42, 286-291.
6. E. Wong, M. Giandomenico, Chem. Rev. 1999, 99, 2451-2466.
7. J. Reedijk, Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 3611-3616.
8. K. M. Williams, C. Rowan, J. Mitchell, Inorg. Chem. 2004, 43, 1190-1196.
9. M. Curic, L. J. Tusek-Bozic, D. Vikic-Topic, V. Scarcia, A. Furlani, J. Balzarini, E. De Clercq, J. Inorg. Biochem. 1996, 63, 129-142.
10. S. Kirschner, Y. K. Wei, D. Francis, J. S. Bergman, Med. Chem. 1966, 9, 369-372.
11. A. A. Grinberg, J. S. Warschavski, M. J. Gelfman, N. W. Kisseleva, D. B. Smolenskaya, Zh. Neorg. Khim. 1968, 13, 803-813.
12. J. D. Higgins, L. Neely, S. Fricker, J. Inorg. Biochem. 1993, 49, 149-156.
13. T. A. Al-Allaf, L. J. Rashan, Boll. Chim. Farm. 2001, 140, 205-210.
14. T. A. Al-Allaf, M. T. Ayoub, L. J. Rashan, J. Inorg. Biochem. 1990, 38, 47-56.
15. T. A. Al-Allaf, L. J. Rashan, Eur. J. Med. Chem. 1998, 33, 817-820.
16. T. A. Al-Allaf, L. J. Rashan, R. F. Khuzaie, W. F. Halseh, Asian J. Chem. 1997, 9, 239-246.
17. T. A. Al-Allaf, L. J. Rashan, A. S. Abu-Surrah, R. Fawzi, M. Steimann, Transition Met. Chem. 1998, 23, 403-406.
18. E. Budzisz, M. Malecka, I.-P. Lorenz, P. Mayer, R. Kwiecień, P. Paneth, U. Krajewska, M. Rozalski, Inorg. Chem. 2006, 45, 9688-9695.
19. M. Gabor (Ed.), The Pharmacology of Benzopyrone Derivatives and Related Compounds, Akademiai Kiado, Budapest, 1988, pp. 91-126.
20. K. Kostka, E. Zyner, Chem. Anal. (Warsaw) 1979, 24, 103-108.
21. K. Kostka, E. Zyner, Chem. Anal. (Warsaw) 1980, 25, 61-68.
22. E. Budzisz, U. Krajewska, M. Rozalski, A. Szulawska, M. Czyz, B. Nawrot, Eur. J. Pharmacol. 2004, 502, 59-65.
23. B. S. Holla, P. M. Akbarali, M. K. Shivanada, Farmaco 2000, 55, 256-263.
24. E. Plaska, M. Aytemir, T. Uzbay, D. Erol. Eur. J. Med. Chem. 2001, 36, 539-543.
25. N. Gokham, A. Yesilada, G. Ucar, K. Erol, A. A. Bilin, Arch. Pharm. Med. Chem. 2003, 336, 362-371.
26. K. Sakai, Y. Tomista, T. Ue, K. Goshima, M. Ohminato, T. Tsubomura, K. Matsumoto, K. Chmura, K. Kawakami, Inorg. Chim. Acta 2000, 297, 64-71.
27. N. J. Wheate, C. Cullinane, L. K. Webster, J. G. Collins, Anticancer Drug Des. 2001, 16, 91-98.
28. M. Gabor (Ed.), The Pharmacology of Benzopyrone Derivatives and Related Compounds, Akademiai Kiado, Budapest 1988, pp. 179-223.
29. G. Baker, G. Ellis, J. Med. Chem. 1973, 6, 87-89.
30. A. M. El-Nagger, A. M. Abdel-El-Salam, F. S. M. Ahmed, M. S. A. Latif, Pol. J. Chem. 1981, 55, 793-798.
31. K. A. Ohemeng, C. F. Schwender, K. P. Fu, J. F. Barrett, Bi oorg. Med. Chem. Lett. 1993, 3, 225-230.
32. G. K. Patnaik, K. K. Banaudha, K. A. Khan, A. Shoeb, B. N. Dhawan, Planta Med. 1987, 53, 517-520.
33. X. Shao, D. H. L. Ekstrand, R. Bhikhabhai, C. F. R. Kallander, J. S. Gronowitz, Antiviral Chem. Chemother. 1997, 38, 149-159.
34. E. Middleton, C. Kandaswami, "The Impact of Plant Flavonoids on Mammalian Biology: Implications for Immunity, Inflammation and Cancer", in The Flavonoids: Advances in Research since 1986 (Ed.: J. B. Harborne), Chapman Hall, London, 1994, pp. 619-652.
35. D. Jiang, R. Deng, J. Wu, Wuji Huaxue 1989, 5, 21-28.
36. R. Deng, J. Wu, Y. Long, Bull. Soc. Chim. Belg. 1992, 101, 439-443.
37. I. Kostova, I. Manolov, S. Konstantinov, M. Karaivanova, Eur. J. Med. Chem. 1999, 34, 63-68.
38. I. Manolov, I. Kostova, T. Netzeva, S. Konstantinov, M. Karaivanova, Arch. Pharm. Pharm. Med. Chem. 2000, 333, 93-98.
39. I. Kostova, I. Malonov, M. Karaivanova, Arch. Pharm. Pharm. Med. Chem. 2001, 334, 157-162.
40. V. D. Karaivanova, I. Malonov, M. L. Minassyan, N. D. Danchev, S. M. Samurova, Pharmazie 1994, 49, 856-857.
41. K. B. Gudasi, R. V. Shenoy, R. S. Vavadi, M. S. Patil, S. A. Patil, Chem. Pharm. Bull. (Tokyo) 2005, 53, 1077-1082.
42. I. Kostova, G. Momekov, M. Zaharieva, M. Karaivanova, Eur. J. Med. Chem. 2005, 40, 542-551.
43. I. Manolov, S. Raleva, P. Genova, A. Savov, L. Froloshka, D. Dundarova, R. Argirova, Bioorg. Chem. Applications 2006, 1-7.
44. J. Kasparkova, V. Marini, Y. Najareh, D. Gibson, V. Brabec, Biochemistry 2003, 42, 6321-6332.
45. I. Kostova, Anti-Cancer Agents-Med. Chem. 2006, 6, 19-32.
46. F. Marchetti, C. Pettinari, R. Pettinari, Coord. Chem. Rev. 2005, 249, 2909-2945.
47. Y. Wan, M. Alterman, M. Larhed, A. Hallberg, J. Org. Chem. 2002, 67, 6232-6235.
48. G. Zon, Prog. Med. Chem. 1982, 19, 205-246.
49. H. Lindemann, E. Harbers, Arzneim.-Forsch. 1980, 30, 2075-2080.
50. A. Lacko, P. Hudziec, G. Mazur, Nowotworv 2000, 50, 609-614.
51. S. Rajski, R. M. Williams. Chem. Rev. 1998, 98, 2723-2795.
52. R. J. Knox, F. Friedlos, F. D. A. Lydall, Cancer Res. 1986, 46, 1972-1979.
53. R. Preussmann, H. Schneider, F. Epple, Arzneim.-Forsch. 1969, 19, 1059-1073.
54. E. Zyner, J. Graczyk, J. Ochocki, Pharmazie 1999, 54, 945-946.
55. J. T. Wrobel, Preparatyka i elementy syntezy organicznej. PWN, Warszawa, 1983, pp. 9-52.
56. G. M. Coppola, R. W. Dodsworth, Synthesis 1981, 7, 523-524.
57. S. Klutchko, J. Shavel, M. von Strandtmann, J. Org. Chem. 1974, 39, 2436-2437.
58. P. Babin, J. Dunogues, M. Petraud, Tetrahedron 1981, 37, 1131-1139.
59. R. Radomski, M. Radomska, M. Dankowski, K. Szajowska, Z. Wisialski, Comput. Chem. 1995, 19, 303-323.
60. R. J. Moteksjtis, A. E. Martell, Can. J. Chem. 1982, 60, 168-173.
61. A. Izquierdo, J. L. Beltram, Anal. Chim. Acta 1986, 181, 87-96.
62. Stoe, Cie, Software for IPDS-II, Darmstadt, Germany, 2000.
63. Z. Otwinowski, W. Minor. "Processing of X-ray Diffraction Data Collected in Oscillation Mode", in Methods in Enzy mology. vol. 276: Macromolecular Crystallography (Eds.: C. W. Carter Jr, R. M. Sweet, Academic Press, New York, 1997, part A, p. 307.
64. G. M. Sheldrick, SHELXS86 Program for Crystal Structure Solution, University of Göttingen, Germany, 1986.
65. G. M. Sheldrick, SHELX97 Programs for Crystal Structure Analysis, University of Göttingen, Germany, 1997.
66. A. L. Spek, PLATON - Molecular Geometry Program, University of Utrecht, The Netherlands, 1998.
67. E. Budzisz, E. Brzezinska, U. Krajewska, M. Rozalski, Eur. J. Med. Chem. 2003, 38, 597-603.